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Summary statement (15-30 words) 
The 3D organotypic model enabled the study of the complex pancreatic tumour 
microenvironment in vitro, where the pro-tumour influence by two of the major non-
malignant cell types were visualised. 
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Abbreviations 
 
ECM  Extra-cellular matrix 
EMT  Epithelial-mesenchymal transition 
TAM  Tumour-associated macrophage 
TGF-β  Transforming growth factor β 
TPSC  Tumour-associated pancreatic stellate cell 
ZEB1  Zinc finger E-box binding homeobox 1 
ZO-1  Zona occludens protein 1 / tight junction protein 1 
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Abstract 
Pancreatic cancer is associated with a highly abundant stroma and low-grade inflammation. In 
the local tumour microenvironment, elevated glucose levels, the presence of tumour-
associated stellate cells and macrophages are hypothesized to promote the tumour progression 
and invasion. The present study investigated the influence by the microenvironment on 
pancreatic cancer cell invasion in vitro. After co-culture with tumour-associated pancreatic 
stellate cells (TPSCs), pancreatic cancer cells displayed up to 8-fold reduction in levels of 
epithelial-mesenchymal transition (EMT) markers E-cadherin and ZO-1, while β-catenin and 
vimentin levels were increased. A 3D organotypic model showed that TPSCs stimulated 
pancreatic cancer cell invasion, both as single cell (PANC-1) and cohort (MIAPaCa-2) 
invasion. The combined presence of TPSCs and M2-like macrophages induced invasion of the 
non-invasive BxPC-3 cells. High glucose conditions further enhanced changes in EMT 
markers as well as the cancer cell invasion. In summary, co-culture with TPSCs induced 
molecular changes associated with EMT in pancreatic cancer cells, regardless of 
differentiation status, and the organotypic model demonstrated the influence of 
microenvironmental factors, such as glucose, stellate cells and macrophages, on pancreatic 
cancer cell invasion.  
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Introduction 
Pancreatic cancer is characterised by a dense desmoplastic stroma, which may constitute the 
majority of the tumour mass. The stroma creates a tumour permissive niche and supports 
tumour progression, local invasion, metastasis and act as a treatment barrier (Whatcott et al., 
2015, Erkan et al., 2012, Jaster and Emmrich, 2008). It is now widely accepted that the 
pancreatic stellate cells, myofibroblast-like cells in the pancreatic microenvironment, are 
responsible for this stromal reaction due to their ability to produce large quantities of ECM 
and influence the composition and turnover of ECM proteins (Yen et al., 2002, Erkan et al., 
2009, Apte et al., 2004). In addition, they may promote the pathogenesis of pancreatic cancer 
by creating a favourable tumour microenvironment through secretion of growth- and 
angiogenic factors as well as stimulating cancer cell migration (Tod et al., 2013, Hwang et al., 
2008, Masamune et al., 2008).  Although pancreatic stellate cells have an established role in 
the desmoplastic stroma, further investigations are needed to elucidate the influence by 
paracrine communication and cell-cell interactions with the tumour microenvironment on 
invasive properties of the cancer cells.  
 
In order for cancer cells to disseminate and metastasise, the epithelial phenotype and cell-cell 
adhesions are down-regulated in favour of a more mesenchymal-like phenotype. This process 
of epithelial-mesenchymal transition (EMT) has been acknowledged as an intrinsic part of 
cancer progression (Castellanos et al., 2013, Hotz et al., 2007, Nakajima et al., 2004). The 
most significant events are down-regulation of E-cadherin, upregulation of transcription 
factors slug and snail, and induced expression of vimentin and N-cadherin. With the complex 
microenvironment around this highly invasive tumour type, further understanding regarding 
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the local interplay between present cell types and soluble factors is needed to elucidate key 
mechanisms and interactions for potential future targets.. 
 
Pancreatic cancer is associated with low grade inflammation and one of the major risk factors 
for pancreatic cancer is chronic pancreatitis (Greer and Whitcomb, 2009, Lowenfels et al., 
1993). The local inflammation involves a diverse leukocyte population of which a subtype of 
macrophages, commonly classified as tumour-associated macrophages (TAMs) or M2-like 
macrophages, is a major component. Macrophages are generally divided into two subtypes: 
classically activated inflammatory M1 macrophages and alternatively activated M2 
macrophages (Murray and Wynn, 2011, Martinez et al., 2008). However, due to their 
plasticity, it is now recognised that macrophages adjust to each unique local 
microenvironment and the M1/M2 paradigm are merely ends of a phenotype spectrum 
(Ruffell et al., 2012, Qian and Pollard, 2010). TAMs are frequently found at the tumour 
periphery where they supply matrix remodelling enzymes and stimulate local invasion. TAMs 
may also play a role in EMT to facilitate dissemination of tumour cells, and in regulating the 
local inflammation to block anti-tumour responses (Neyen et al., 2013, Green et al., 2009, 
Wormann et al., 2014). 
 
In addition to inflammation, pancreatic cancer is commonly linked to type 2 diabetes (Chari et 
al., 2008, Pannala et al., 2008). Diabetes and obesity have both been recognised among the 
top modifiable risk factors for pancreatic cancer (Bao et al., 2011, Huxley et al., 2005). At the 
time of diagnosis, up to 80% of cancer patients demonstrate reduced glucose tolerance or new 
onset type 2 diabetes, with elevated blood glucose levels as a consequence (Pannala et al., 
2008, Permert et al., 1993). Hyperglycemia may both fuel tumour cell proliferation as well as 
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impair response to treatment (Karnevi et al., 2013). However, its role in tumour cell 
invasiveness remains poorly understood.  
 
The complex interplay within the tumour microenvironment has been difficult to study 
through conventional 2D models in vitro. In the present study, a 3D organotypic model was 
established to mimic the complex tumour microenvironment and cellular interactions present, 
with the aim to investigate the influence by pancreatic stellate cells, M2-like macrophages and 
hyperglycemia on pancreatic cancer cell invasion. In addition, co-culture studies were 
performed to study the influence by paracrine signalling on EMT in pancreatic cancer cells. 
 
7 
 
Material and methods 
 
Materials 
All materials and reagents were purchased from Sigma-Aldrich unless stated otherwise (St 
Louis, MO, USA). Cell culture medium, fetal bovine serum, penicillin-streptomycin, insulin-
transferrin-selenium (ITS) and L-glutamine were obtained from Invitrogen (Paisley, UK). 
Antibody specifications, concentrations and suppliers are listed in Table 1. 
 
Cell culture 
The moderately differentiated BxPC-3, and poorly differentiated PANC-1 and MIAPaCa-2 
human pancreatic cancer cell lines were purchased from ATCC-LGC Standards (Manassas, 
VA, USA). The cells were maintained in RPMI1640 or DMEM medium supplemented with 
10% fetal bovine serum (FBS) and antibiotics (100 U/ml penicillin and 100 µg/ml 
streptomycin) in a humified 5% CO2 atmosphere at 37
°C. The monocytic cell line THP-1 was 
purchased from ATCC and maintained in RPMI1640 medium supplemented with 10% FBS, 
0.1% 2-mercaptoethanol and antibiotics as above. The tumour-derived pancreatic stellate cells 
(TPSCs) are conditionally immortalised human stellate cells generated from a pancreatic 
ductal adenocarcinoma specimen as previously described (Rosendahl et al., 2015). Briefly, 
cells were isolated by the outgrowth method and transformed with a temperature-sensitive 
SV40 large T-antigen and human telomerase. The TPSCs were maintained at 33°C where 
proliferation was sustained. Prior to experiments, cells were grown to 80% confluence and 
transferred to 37°C for seven days to inactivate the SV40LT and resume their primary 
phenotype. The cells were maintained in RPMI1640 medium supplemented with 10% FBS, 
1% ITS and antibiotics as above. All experiments were performed in glucose-free RPMI1640 
or DMEM supplemented with 5 mM (normal) or 25 mM (high) D-glucose, 2 mM L-
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glutamine, and antibiotics as above (normal or high glucose medium; NGM or HGM), unless 
stated otherwise.  
 
M2-like macrophage differentiation 
The THP-1 cells were seeded in T-25 flasks (7.5x105) in NGM or HGM supplemented with 
10% FBS and left overnight. The cells were then incubated with 60 ng/ml phorbol 12-
myristate 13-acetate (PMA) for 24h, followed by 48h incubation with 60 ng/ml PMA, 20 
ng/ml IL-4 and 20 ng/ml IL-13. M2-like macrophage differentiation was verified 
morphologically under microscope and by multicolour flow cytometry (CD11c (clone B-ly6), 
CD14 (clone M5E2), CD206 (clone 19.2) and HLA-DR (clone G46-6); BD Biosciences, San 
Diego, CA, USA) using a FACSCalibur (BD Biosciences) dual laser flow cytometer with Cell 
Quest Pro software (BD Biosciences) and analysed using FlowJo software.  
 
Co-culture 
The PANC-1, MIAPaCa-2 and BxPC-3 cell lines were seeded in 6-wells plates (4x105 
cells/well) and co-cultured for 48h with or without TPSCs or M2-like macrophages seeded in 
inserts (3μm pores; 8x105 cells/insert). Alternatively, pancreatic cancer cells were incubated 
with or without 5 ng/ml TGF-β for 48h. The cancer cells were then harvested and transferred 
to inserts (8 μm pores) with NGM or HGM supplemented with 10% FBS in the lower 
chamber. After 6h incubation, cancer cell lysates were collected and stored at -80°C.  
 
Western immunoblotting 
Samples were prepared and Western immunoblotting performed as outlined previously 
(Karnevi et al., 2013). Membranes were incubated overnight at 4°C with anti-human slug, 
claudin-1, ZO-1, ZEB-1, E-cadherin, vimentin or β-catenin primary antibodies. β-actin 
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(BxPC-3) or GAPDH (PANC-1 and MIAPaCa-2) were used as loading controls. The 
following day membranes were washed, incubated with HRP-conjugated secondary antibody 
for 1h and visualised using SuperSignal West Femto Maximum Sensitivity Substrate 
(ThermoFisher Scientific, Waltham, MA, USA). Immunoblotted proteins were detected using 
LI-COR Odyssey system with ImageStudio software (LI-COR Biosciences, Ltd., Cambridge, 
UK) and quantified using ImageJ software (NIH, USA).  
 
3D organotypic assay 
The three-dimensional (3D) organotypic model was set up as described by Moutasim et al and 
Froeling et al (Moutasim et al., 2011, Froeling et al., 2010). To make the gel, a mixture of 3.5 
parts Collagen I (Millipore, Temecula, CA, USA), 3.5 parts Matrigel (Corning, Tewksbury, 
MA, USA), 1 part DMEM 10X, 1 part FBS and 1 part cell suspension was added to 24-well 
plates (1 ml/well) and incubated for 1h at 37oC. The cell suspension contained 2.5x105 TPSCs 
with or without 2.5x105 M2-like differentiated macrophages in NGM or HGM supplemented 
with 10% FBS. After the gels had polymerised, medium was added on top and the gels left 
overnight at 37oC. Cancer cells (5x105) mixed with TPSCs (2.5x105) were then seeded on top 
of the gels and incubated 24h. On day three, the gels were raised by inserting metal grids in 6-
wells plates with collagen-coated nylon sheets placed on top. The gels were transferred to the 
nylon-sheets and medium added to the well up to the bottom of the gel to create an air-liquid 
interface. The medium was changed every 2-3 days. After 7 or 14 days incubation, the gels 
were bisected, formalin fixed and paraffin embedded. 
 
Histological and immunohistochemical analyses 
Staining procedures 
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Paraffin-embedded organotypic gels were sectioned 5 μm thick, deparaffinised and 
rehydrated. For histological evaluation, sections were stained with hematoxylin and eosin 
(H&E) or Masson’s trichrome according to the manufacturer’s instructions. 
Prior to immunohistochemical stainings, sections were subjected to antigen retrieval, either 
using citrate buffer (pH 6) or Tris-EDTA buffer (pH 9), for 10 min at 90°C in waterbath. The 
organotypic sections were subsequently blocked with 5% horse serum, avidin/biotin and 
incubated with anti-human Ki-67 or cytokeratin primary antibodies overnight at 4°C. The 
following day, sections were incubated with HRP-conjugated secondary antibody for 1h, and 
visualised using Vectastain Elite ABC kit and DAB (Vector, Peterborough, UK).  
Prior to immunofluorescence staining, antigen retrieval was performed using citrate buffer as 
above. The sections were subsequently blocked with 5% donkey serum, and incubated with 
anti-human β-catenin, E-cadherin, vimentin or ZO-1 primary antibodies overnight at 4°C. The 
next day, sections were incubated with Alexa Fluor® 555-conjugated secondary antibody for 
1h. The sections were washed and nuclei counterstained with DAPI.  
Quantification 
The organotypic sections were photographed at 20X magnification with CellSens Dimension 
software. Whole slide digital images were captured at 40X magnification using Aperio 
ScanScope slide scanner (Aperio Technologies, Leica Biosystems, Nussloch, Germany). Total 
gel width, thickness of tumour epithelium and distance covered by invading cells were 
analysed with ImageScope software (Leica Biosystems).  
 
Statistical analyses 
Western immunoblot data were analyzed by two-way ANOVA with Bonferroni post-hoc test 
using GraphPad prism software. All graphs are expressed as mean ±SE of a minimum of 
three individual experiments. Statistical analyses of organotypic sections were performed 
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using unpaired two-tailed Student’s t-test using Excel 2010 software. Graphs represent mean  
± SE of six measurements of depth of invasion in relation to total gel width.  A P-value of 
<0.05 was considered statistically significant. 
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Results 
 
TPSCs induced changes associated with EMT in pancreatic cancer cells. 
To investigate the impact of paracrine signalling by stellate cells on EMT, the BxPC-3, 
PANC-1 and MIAPaCa-2 pancreatic cancer cells were cultured in the presence of TPSCs 
without direct cell contact. The moderately differentiated BxPC-3 cells displayed basal 
expression of E-cadherin and the tight junction protein ZO-1, both of which decreased by 
15% (P<0.05) and 4-fold (P<0.001), respectively, in response to TPSCs (Fig. 1A). In 
addition, TPSCs stimulated a 2-fold increased expression of the transcription factor slug 
(P<0.05). Similarly, the poorly differentiated PANC-1 cells displayed 8-fold (P<0.001) and 2-
fold (P<0.05) reduced levels of E-cadherin and ZO-1, respectively, after TPSC co-culture 
(Fig. 1A), of which ZO-1 was further reduced in the presence of high glucose levels (P<0.05). 
PANC-1 also showed almost 2-fold increased levels of the mesenchymal marker vimentin 
following co-culture (P<0.001). Lastly, MIAPaCa-2, the poorly differentiated and most 
mesenchymal and spindle-like cells in culture, lacked basal E-cadherin expression but 
demonstrated strong expression of vimentin, which was further increased by TPSC-derived 
factors (P<0.01; Fig 1A). In addition, elevated ZO-1 (P<0.01) and β-catenin (P<0.05) levels 
were observed following TPSC co-culture, and more pronounced under high glucose 
conditions.  
The TPSC-induced EMT changes were similar to or greater than those by the known EMT-
inducer TGF-β (Fig. 1A-B). These results demonstrated that soluble factors and paracrine 
signalling by TPSCs induced molecular changes associated with EMT in pancreatic cancer 
cells of diverse differentiation status.   
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TPSCs enhanced invasion by PANC-1 and MIAPaCa-2 cells. 
In order to mimic the tumour microenvironment and investigate the influence by cell-cell 
communication between pancreatic cancer cells and TPSCs on cancer cell invasion, a 3D 
organotypic model was established. No signs of invasion was observed for BxPC-3 cells after 
7 or 14 days culture, regardless of the presence of pancreatic stellate cells or glucose levels 
(Fig 2A, C). In contrast, PANC-1 and MIAPaCa-2 cells displayed induced invasion at day 7 
in the presence of TPSCs, which was 28-31% (P<0.01) and 11-14% (P<0.05) higher than 
compared with control gels without TPSCs, respectively (Fig. 2A, C). The invasion was 
further increased with 20-40% by day 14 (P<0.01), and under higher glucose levels. On 
average, the cell lines’ invasive front was seen at the depth of 58% of the total gel width, 
compared with 43% at day 7. The two cell lines displayed different manners of invasion, 
where PANC-1 cells invaded the gel as single cells or small cell clusters (<5 cells) and 
MIAPaCa-2 displayed cohort invasion. The invasion was further verified by Trichrome 
staining of collagen fibres between invading cells and the tumour cell epithelium (Fig 2B), 
and cytokeratin staining of epithelial cells (Fig. S1).  
 
Invading cell types displayed high levels of vimentin and lacked E-cadherin. 
Associations between invasion pattern and EMT was further studied and the organotypic gel 
sections in the presence of TPSCs were evaluated for cellular localization of the EMT 
markers E-cadherin, β-catenin, vimentin and ZO-1. No changes in EMT marker levels were 
observed between days 7 and 14. The non-invasive and vimentin negative BxPC-3 cells 
displayed membranous E-cadherin and β-catenin expression throughout the tumour 
epithelium, with a weak membranous ZO-1 expression at the leading edge (data not shown). 
PANC-1 cells in contrast, demonstrated distinct vimentin expression in both the tumour 
epithelium and in invading cells (Fig. 3). The vimentin intensity was more pronounced in high 
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glucose conditions. A diffuse cytosolic E-cadherin and ZO-1 expression, and sparse 
membranous β-catenin expression was observed in a limited number of cells (Fig. 3). 
Similarly, the vimentin-positive MIAPaCa-2 tumour epithelium lacked E-cadherin expression 
but displayed sparse β-catenin and diffuse cytosolic ZO-1, with stronger intensity at the 
invasive front (data not shown).   
 
M2-like macrophages facilitated invasion of the epithelial-like BxPC-3 pancreatic cancer 
cells. 
The joint effects of TPSCs and M2-like macrophages in the microenvironment on tumour cell 
invasion were investigated next. After 14 days organotypic cultures in the presence of both 
M2-like macrophages and TPSCs, invasion of the previously non-invasive BxPC-3 cells was 
induced, compared with TPSC alone (Fig 4A; P<0.05). The BxPC-3 tumour epithelium made 
up for less than 20% of the total gel width, both with and without the presence of M2-like 
macrophages, while the induced invasion was displayed at the average depth of 40% of the 
total gel width. The BxPC-3 cells displayed characteristics of cohort invasion and the invasion 
was further enhanced by up to 40% in high glucose conditions (P<0.05). No significant 
difference in invasion was observed for PANC-1 and MIAPaCa-2 cells in the presence of M2-
like macrophages in this model, compared with TPSCs alone (Fig 4B).   
 
The presence of M2-like macrophages was associated with expression of mesenchymal 
markers in invading BxPC-3 cells. 
To study if cell-cell interactions and the combined presence of macrophages and pancreatic 
stellate cells influenced EMT in invading cells, the cellular expression of selected EMT 
markers were evaluated. The presence of M2-like macrophages stimulated invasion with 
concomitant changes in EMT in invading BxPC-3 cell cohorts, but not in the tumour 
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epithelium, compared with TPSCs alone (Fig. 5). The BxPC-3 cells displayed loss of both E-
cadherin and β-catenin in invading cell populations compared with the tumour cell epithelium 
(Fig. 5). In addition, a moderate expression of vimentin was induced in invading groups of 
BxPC-3 cells in the presence of M2-like macrophages. ZO-1 expression was observed at the 
leading edge in the tumour epithelium and was considerably enriched in invading cell cohorts 
(Fig. 5). The expression of the EMT markers were similar between low 5 mM and high 25 
mM glucose levels. No differences in EMT markers were observed in PANC-1 and 
MIAPaCa-2 cells in the presence of M2-like macrophages compared with TPSCs alone (data 
not shown).  
 
Macrophage-derived factors stimulate changes in EMT-associated markers  
Finally, the contribution of paracrine signalling and soluble mediators by M2-like 
macrophages on tumour cell EMT was investigated through indirect co-culture between the 
two cell types. M2-like macrophages did not induce changes in the investigated EMT-markers 
to the same extent as TPSCs (Fig 6A). Macrophage-derived factors reduced the levels of slug 
in BxPC-3 (P<0.05), while no changes were seen for E-cadherin or ZO-1. PANC-1 however, 
displayed decreased E-cadherin levels by 25%, but also 2-fold reduced vimentin levels (both 
Ps<0.01). The reduction in vimentin was further enhanced by high glucose conditions 
(P<0.05). ZO-1 was increased in both PANC-1 and MIAPaCa-2 cells.   
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Discussion 
The major non-malignant cellular components of the tumour microenvironment, the 
pancreatic stellate cells and tumour-associated macrophages, have been suggested to be 
involved in the progression of pancreatic cancer by creating a favourable tumour 
microenvironment and stimulate invasion, tumour growth, and development of metastases 
(Hwang et al., 2008, Masamune et al., 2008, Neyen et al., 2013, Green et al., 2009). The 
present study utilized the benefits of a 3D organotypic model to study the joint influence by 
pancreatic stellate cells and M2-like macrophages on the invasive characteristics of pancreatic 
cancer cells. Our results showed TPSC-derived factors to stimulate changes associated with 
EMT in pancreatic cancer cells of diverse differentiation status, and the combined presence of 
M2-like macrophages and TPSCs to induce invasion by the more epithelial-like BxPC-3 cells.  
 
In this study, co-culture with tumour-associated pancreatic stellate cells (TPSCs) stimulated 
changes in EMT-associated proteins for all cell lines investigated. The cancer cells showed 
decreased E-cadherin levels, upregulation of vimentin as well as reduced levels of the tight 
junction protein ZO-1. These results are in line with previous studies where pancreatic stellate 
cells or cancer-associated fibroblasts have been shown to potentially induce EMT in 
pancreatic cancer cells, and thereby facilitate invasion (Kikuta et al., 2010, Froeling et al., 
2009). Furthermore, the present study demonstrates TPSCs to induce EMT-associated 
changes by paracrine communication, regardless of differentiation status. It has been 
hypothesised that TPSCs potentially exert some of their tumour promoting effects through 
TGF-β, a known inducer of EMT. Here, the changes displayed after co-culture with TPSCs 
were similar to the effect of TGF-β treatment. This indicates that TGF-β may at least in part 
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contribute to the TPSC-induced changes in EMT observed. However other factors secreted by 
TPSCs such as uPA, FGF and PDGF may likely also be involved (Rosendahl et al., 2015). 
 
It has been shown that cancer-associated fibroblasts or TPSCs can stimulate migration or 
invasion of cancer cells in vitro, although mainly through 2D models (Hwang et al., 2008, 
Kikuta et al., 2010). The organotypic model has previously displayed favourable results for 
visualisation of cancer cell invasion and interplay with the local microenvironment (Froeling 
et al., 2009, Linde et al., 2012). The results here demonstrate cell-cell interactions with TPSCs 
to stimulate different manners of invasion: single cell invasion (PANC-1) and cohort invasion 
(MIAPaCa-2). The pancreatic cancer cells also displayed significantly increased invasion in 
the presence of TPSCs, compared with gels lacking stellate cells. The epithelial-like BxPC-3 
cells, on the other hand, remained non-invasive with an intact tumour epithelium. The cell 
lines’ invasive behaviour displayed in the organotypic model corresponds to changes in EMT 
markers visualised by Western blot. This strengthens the pro-tumour role of TPSCs in the 
tumour microenvironment, and the evidence of paracrine communication and cell-cell 
interactions with pancreatic cancer cells. Furthermore, it suggests TPSCs to be an important 
target with the potential to regulate invasion and the associated EMT. Previous studies have 
focused on other pro-tumour properties of stellate cells in order to inhibit the tumourigenesis. 
The desmoplastic stroma produced by pancreatic stellate cells has been shown to create a 
treatment barrier around the tumour, limiting bioavailability of drugs (Jaster and Emmrich, 
2008, Erkan et al., 2012, Whatcott et al., 2015). To surpass this barrier, Olive et al. increased 
drug availability and chemotherapy response by targeting the pancreatic stellate cells and 
thereby reducing the stromal compartment before administrating treatment (Olive et al., 
2009). There has however been other studies demonstrating anti-tumour influences by the 
stroma, whereby deleting the stromal compartment results in increased aggressiveness of 
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pancreatic tumours and reduced survival (Rhim et al., 2014, Ozdemir et al., 2014). Based on 
the conflicting results by targeting the stroma, future investigative studies to reduce tumour 
aggressiveness and/or inhibit tumour progression stimulated by pancreatic stellate cells will 
require careful design in order to solely target the pro-tumour properties. 
 
In the local pancreatic tumour microenvironment, tumour-associated macrophages (TAMs) 
play a central role next to the pancreatic stellate cells. In a study with squamous carcinoma 
cells, M2 macrophages together with fibroblasts enhance the invasion rate of cancer cells 
compared to fibroblasts alone (Linde et al., 2012). In a similar manner, the combined presence 
of TPSCs and M2-like macrophages in the present study induced invasion of more epithelial-
like BxPC-3 pancreatic cancer cells, which displayed no invasion in the presence of TPSCs 
alone. Interestingly, the BxPC-3 cells disrupted the previously intact tumour epithelium and 
displayed invasion with an associated loss of E-cadherin expression. Staining of EMT 
markers displayed expression patterns resembling the more poorly differentiated PANC-1 and 
MIAPaCa-2 cells, in particular in the invaded groups of BxPC-3 cells. When investigating the 
influence on EMT-associated markers after co-culture, the M2-like macrophages induced 
changes that differed from those demonstrated by TPSCs-derived factors, such as reduced 
vimentin levels and increased ZO-1. This may be due to differences in secreted factors and 
thereby the paracrine signalling pathways involved. The M2-like macrophages most likely 
stimulate invasion and changes in EMT-markers by secretion of cytokines, MMPs and growth 
factors, which all are associated with invasion, metastasis and ECM degradation (Goswami et 
al., 2005, Baran et al., 2009, Kessenbrock et al., 2010, Kuwada et al., 2003, Lesina et al., 
2011). In studies investigating colon cancer and breast cancer, a chemotactic loop between 
cancer cells and macrophages have been observed where the macrophages stimulate cancer 
cell invasion by secretion of EGF (Green et al., 2009, Goswami et al., 2005). The interplay 
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between TPSCs and macrophages themselves is also of interest, since pancreatic stellate cells 
have been suggested to contribute to local inflammation and recruitment of inflammatory 
cells (Tjomsland et al., 2011, Erez et al., 2010). Erez et al investigated inflammatory profiles 
of cancer-associated fibroblasts in a wide range of cancers, and found similar signatures 
comparing pancreatic cancer to the inflammatory environments present in skin cancer (Erez et 
al., 2010).  
 
In conclusion, TPSCs induced changes associated with EMT in human pancreatic cancer cells 
and stimulated both single cell invasion (PANC-1) and cohort invasion (MIAPaCa-2). This 
suggests the inter-cell communication with pancreatic stellate cells to be central for pancreatic 
cancer cell invasion, and an important potential target to restrict tumour spreading. The 
presence of M2-like macrophages stimulated the invasion further as well as induced invasion 
of more epithelial-like and non-invasive cells. This demonstrates the importance of the 
tumour microenvironment in stimulating cancer progression and cancer cell invasion into 
surrounding tissue and opens up for further investigations in the search of new targets outside 
the tumour itself in order to inhibit the tumour progression. 
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Figure legends 
 
Figure 1. Modulation of EMT markers in three pancreatic cancer cell lines 
Representative images of Western immunoblotting of claudin-1, slug, vimentin, β-catenin, E-
cadherin, ZO-1 and ZEB1 in cell lysates of BxPC-3, PANC-1 and MIAPaCa-2 after 48h co-
culture with TPSCs (A) or 48h exposure to 5 ng/ml TGF-β (B) under nomal (5 mM) or high 
(25 mM) glucose levels. β-actin (BxPC-3) or GAPDH (PANC-1, MIAPaCa-2) were used as 
loading controls. Graphs represent quantification of a minimum of three individual 
experiments with results presented as mean ± SE, relative to control. Statistical analyses 
testing the significant difference between co-culture and control for both glucose levels were 
performed using two-way ANOVA with Bonferroni post-hoc test. N.D. = not detected  
 
Figure 2. The invasive properties of pancreatic cancer cells using a 3D organotypic 
model 
Histological analyses of gel sections from organotypic models of BxPC-3, PANC-1 or 
MIAPaCa-2 after 7 or 14 days culture in normal (5 mM) or high (25 mM) glucose conditions. 
A) H&E staining of organotypic models with or without TPSCs, B) Trichrome staining 
displaying collagen fibre in blue, C) graphs represent quantification of depth of invasion (% 
of total gel width) at day 7 or 14 of gels with TPSCs (empty bars) or without TPSCs (filled 
bars) as mean ± SE. Representative images (20X magnification) from one of three 
independent experiments are shown. Scale bar = 50 μm. 
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Figure 3. Distribution of EMT markers in tumour cell epithelium and invading cells in 
3D organotypic model 
Immunofluorescent staining of EMT markers vimentin, E-cadherin, β-catenin and ZO-1 in gel 
sections from organotypic model of moderately invasive PANC-1 after 14 days culture in 
normal (5 mM) or high (25 mM) glucose. Nuclei were counterstained with DAPI. 
Representative images (20X magnification) from one of three independent experiments are 
shown. Scale bar = 50 μm. 
 
Figure 4. Influence by M2-like macrophages on pancreatic cancer cell invasion 
H&E staining of gel sections from organotypic models of A) BxPC-3, B) PANC-1 or 
MIAPaCa-2 cells after 14 days culture in the presence of TPSCs, with or without M2-like 
macrophages, under normal (5 mM) or high (25 mM) glucose conditions. Graph display 
quantification of depth of invasion (% of total gel width) at day 7 and 14 of BxPC-3 gels with 
M2-like macrophages (empty bars) or TPSCs alone (filled bars) as mean ± SE. Representative 
images (20X magnification) from one of three individual experiments are shown. Scale bar = 
50 μm. 
 
Figure 5. Distribution of EMT markers in tumour cell epithelium and invasive ccells in 
the presence of both TPSCs and M2-like macrophages 
Immunofluorescent staining of EMT markers vimentin, E-cadherin, β-catenin and ZO-1 in gel 
sections from organotypic models of BxPC-3 pancreatic cancer cells in the presence of 
TPSCs, with or without M2-like macrophages, under normal (5 mM) or high (25 mM) 
glucose conditions. Nuclei were counterstained with DAPI. Representative (20X 
magnification) from one of three independent experiments is shown. Scale bar = 50 μm. 
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Figure 6. Influence by macrophage-derived factors on EMT-associated markers 
Representative images of Western immunoblotting of claudin-1, slug, vimentin, β-catenin, E-
cadherin, ZO-1 and ZEB1 in cell lysates of BxPC-3, PANC-1  and MIAPaCa-2  after 48h co-
culture with M2-like macrophages. β-actin (BxPC-3) or GAPDH (PANC-1 and MIAPaCa-2) 
were used as loading controls. Graphs represent quantification of a minimum of three 
independent experiments with data presented as mean ± SE, relative to control. Statistical 
analyses testing the significant difference between co-culture and control for both glucose 
levels were performed using two-way ANOVA with Bonferroni post-hoc test. N.D. = not 
detected 
 
 
 
 
